Founded in 2024, we have been privileged to support a growing technology-driven clients, including:

• Bel Devices – consumer and professional audio solutions
• Beta-O2 Technologies Ltd. – bioartificial pancreas and cell-therapy platforms
• Bind-X International GmbH – biotechnology for sustainable soil and material binding
• Bios S.r.l. – medical imaging and vascular diagnostic systems
• Cognyte Technologies – investigative analytics and security intelligence software
• EMI Integrated Systems Ltd. – electromedical and therapeutic devices
• Hanita Lenses Ltd. – intraocular lenses and ophthalmic technologies
• INHA University Research and Business Foundation – university-based R&D and technology transfer
• Korea University R&D Foundation – academic research commercialization
• Lumenis Be Ltd. – laser and energy-based medical devices
• Pollogen Ltd. – aesthetic medical device technologies
• Sarine Technologies – diamond and gemstone analysis systems
• Seoul National University Hospital – leading clinical research and medical innovation hub
• Zhejiang Flashforge 3D Technology Co., Ltd. – 3D printing hardware and materials

Our Focus

At Leo, we primarily represent small and medium-sized enterprises (SMEs) as well as larger companies that actively enforce and manage dynamic patent portfolios.

By partnering with organizations that maintain ongoing R&D, we are able to engage deeply with their technologies, business, and long-term objectives. This close collaboration enables us to operate as an extension of the in-house team providing practical IP strategies aligned with commercial goals.

Our practice is built to support clients requiring complex, multi-jurisdictional strategies. We work with companies that benefit from sustained engagement and from our detailed understanding of their innovation landscape.